AMPK was activated by 2-hydroxy-6-tridecylbenzoic acid and in turn upregulated the expression of cytochrome P450 1B1 (CYP1B1), as well as reversing the EMT processes in breast cancer cells [249]. The gene discussed is PRKAA2; the disease is breast carcinoma.